$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Instructions on the pharmacological effects of Ivonib (Tosuvo) and suitable groups for use
2026-02-01 22:25:32
Check Details
What are the common side effects of Mitotane? Patients need to be vigilant when taking medication
2026-02-01 22:25:32
Check Details
Pemigatinib (Pemigatinib) market price per box and drug purchase cost reference instructions
2026-02-01 22:25:32
Check Details
Which company is developing and producing Erdafitinib and its global launch status?
2026-02-01 22:25:32
Check Details
The latest official instructions for Erlotinib (Loret) cover usage, dosage and precautions
2026-02-01 22:25:32
Check Details
A complete analysis of the main efficacy, mechanism of action and scope of indications of tofacitinib (Shangjie)
2026-02-01 22:25:32
Check Details
Reasonable standard usage and dosage of cycloserine in different patients and different disease stages
2026-02-01 22:25:32
Check Details
Is linezolid (Siwo) in tablet form and what are the differences in use between different dosage forms?
2026-02-01 22:25:32
Check Details
Summary of the differences in efficacy between ribociclib (Calilon) and palbocicillin in the combined or comparative treatment of breast cancer
2026-02-01 22:25:32
Check Details
Is cemiplimab an immune drug or a targeted drug and an in-depth analysis of its PD-1 inhibition mechanism
2026-02-01 22:25:32
Check Details
Which class of drugs does Daprodustat belong to and its position and characteristics among HIF-PH inhibitors?
2026-02-01 22:25:32
Check Details
Is durvalumab (durvalumab) an immunological drug or a targeted drug and analysis of its mechanism
2026-02-01 22:25:32
Check Details
1
2
...
2413
2414
2415
2416
2417
2418
2419
...
2440
2441
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
FDA Approves Zanidatamab (Ziihera): HER2 Bispecific Antibody Plus Immunotherapy for First-Line Gastric Cancer
2
Neurokinin Receptor Antagonists: A Non-Hormonal Approach to Menopausal Hot Flashes and Sleep Disturbances
3
FDA Approves Tauklarify for Tau PET Imaging in Alzheimer's Disease Assessment
4
First CELMoD Drug Zenbexus Wins FDA Accelerated Approval for Multiple Myeloma
5
FDA Approves First mRNA Flu Vaccine mFLUSIVA
6
FDA Approves Orzeyful, the World's First Orexin Receptor Agonist for Narcolepsy Type 1, Ushering in a New Era of Root-Cause Therapy
7
FDA Approves Lytenava: First Ophthalmic Bevacizumab for Wet AMD
8
AbbVie’s TEPKINLY (epcoritamab) Plus R² Granted EU Approval for Relapsed/Refractory Follicular Lymphoma
9
Global Oncology Update: Breakthroughs in Advanced Cancer Survival and Novel Therapies
10
Phase 1 Study Progress of Ceralasertib in Combination with Durvalumab for Advanced NSCLC and HNSCC
11
Global Breakthroughs in Cancer Drugs and Advanced Treatment Technologies
12
ROS and Cancer: The Potential of Natural Antioxidants